| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.SCHRES.2008.11.006 |
| P698 | PubMed publication ID | 19056247 |
| P2093 | author name string | Akihiro Takano | |
| Hidehiko Takahashi | |||
| Hiroshi Ito | |||
| Ryosuke Arakawa | |||
| Tetsuya Suhara | |||
| Fumihiko Yasuno | |||
| Haruo Kashima | |||
| Yoshiro Okubo | |||
| Miho Ota | |||
| Masaki Okumura | |||
| Harumasa Takano | |||
| Motoichiro Kato | |||
| Yota Fujimura | |||
| Ryohei Matsumoto | |||
| Shoko Nozaki | |||
| Akihiko Otsuka | |||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| dopamine | Q170304 | ||
| P304 | page(s) | 78-84 | |
| P577 | publication date | 2008-12-04 | |
| P1433 | published in | Schizophrenia Research | Q7431607 |
| P1476 | title | Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET. | |
| P478 | volume | 108 |
| Q37765676 | A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia |
| Q37678649 | Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. |
| Q55305236 | Cognitive Function and Monoamine Neurotransmission in Schizophrenia: Evidence From Positron Emission Tomography Studies. |
| Q50192659 | Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis |
| Q99418608 | Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [18F]DOPA and [11C]raclopride PET study in first-episode psychosis |
| Q37480047 | Executive function, neural circuitry, and genetic mechanisms in schizophrenia |
| Q33746294 | Eye-blink rate predicts individual differences in pseudoneglect |
| Q36992322 | Glutamate and dopamine in schizophrenia: an update for the 21st century |
| Q89000776 | Human cathelicidin LL-37 - Does it influence the homeostatic imbalance in mental disorders? |
| Q30854782 | Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation |
| Q37559303 | Influence of O-methylated metabolite penetrating the blood-brain barrier to estimation of dopamine synthesis capacity in human L-[β-(11)C]DOPA PET |
| Q40733200 | Interactions between glutamate, dopamine, and the neuronal signature of response inhibition in the human striatum. |
| Q34703195 | Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials |
| Q37256211 | Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study |
| Q30383611 | Molecular substrates of schizophrenia: homeostatic signaling to connectivity |
| Q34527656 | Pathway-Specific Dopamine Abnormalities in Schizophrenia |
| Q40550785 | Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet |
| Q64053015 | Preliminary evidence of increased striatal dopamine in a nonhuman primate model of maternal immune activation |
| Q48219402 | Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study |
| Q38848472 | Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions |
| Q37825635 | Presynaptic dopamine in schizophrenia. |
| Q53223015 | Relation between presynaptic and postsynaptic dopaminergic functions measured by positron emission tomography: implication of dopaminergic tone. |
| Q34250017 | Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies |
| Q33821967 | The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding |
| Q38232366 | The neurobiology and treatment of first-episode schizophrenia |
| Q33897463 | The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function |
| Q37820985 | The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia |
Search more.